First Time Loading...

SOL SpA
MIL:SOL

Watchlist Manager
SOL SpA Logo
SOL SpA
MIL:SOL
Watchlist
Price: 33.6 EUR -0.15% Market Closed
Updated: May 8, 2024

Intrinsic Value

SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. [ Read More ]

The intrinsic value of one SOL stock under the Base Case scenario is 22.62 EUR. Compared to the current market price of 33.6 EUR, SOL SpA is Overvalued by 33%.

Key Points:
SOL Intrinsic Value
Base Case
22.62 EUR
Overvaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
SOL SpA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SOL stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
SOL SpA

Provide an overview of the primary business activities
of SOL SpA.

What unique competitive advantages
does SOL SpA hold over its rivals?

What risks and challenges
does SOL SpA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for SOL SpA.

Provide P/S
for SOL SpA.

Provide P/E
for SOL SpA.

Provide P/OCF
for SOL SpA.

Provide P/FCFE
for SOL SpA.

Provide P/B
for SOL SpA.

Provide EV/S
for SOL SpA.

Provide EV/GP
for SOL SpA.

Provide EV/EBITDA
for SOL SpA.

Provide EV/EBIT
for SOL SpA.

Provide EV/OCF
for SOL SpA.

Provide EV/FCFF
for SOL SpA.

Provide EV/IC
for SOL SpA.

Show me price targets
for SOL SpA made by professional analysts.

What are the Revenue projections
for SOL SpA?

How accurate were the past Revenue estimates
for SOL SpA?

What are the Net Income projections
for SOL SpA?

How accurate were the past Net Income estimates
for SOL SpA?

What are the EPS projections
for SOL SpA?

How accurate were the past EPS estimates
for SOL SpA?

What are the EBIT projections
for SOL SpA?

How accurate were the past EBIT estimates
for SOL SpA?

Compare the revenue forecasts
for SOL SpA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of SOL SpA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of SOL SpA against its competitors.

Analyze the profit margins
(gross, operating, and net) of SOL SpA compared to its peers.

Compare the P/E ratios
of SOL SpA against its peers.

Discuss the investment returns and shareholder value creation
comparing SOL SpA with its peers.

Analyze the financial leverage
of SOL SpA compared to its main competitors.

Show all profitability ratios
for SOL SpA.

Provide ROE
for SOL SpA.

Provide ROA
for SOL SpA.

Provide ROIC
for SOL SpA.

Provide ROCE
for SOL SpA.

Provide Gross Margin
for SOL SpA.

Provide Operating Margin
for SOL SpA.

Provide Net Margin
for SOL SpA.

Provide FCF Margin
for SOL SpA.

Show all solvency ratios
for SOL SpA.

Provide D/E Ratio
for SOL SpA.

Provide D/A Ratio
for SOL SpA.

Provide Interest Coverage Ratio
for SOL SpA.

Provide Altman Z-Score Ratio
for SOL SpA.

Provide Quick Ratio
for SOL SpA.

Provide Current Ratio
for SOL SpA.

Provide Cash Ratio
for SOL SpA.

What is the historical Revenue growth
over the last 5 years for SOL SpA?

What is the historical Net Income growth
over the last 5 years for SOL SpA?

What is the current Free Cash Flow
of SOL SpA?

Discuss the annual earnings per share (EPS)
trend over the past five years for SOL SpA.

Financials

Balance Sheet Decomposition
SOL SpA

Current Assets 734.4m
Cash & Short-Term Investments 132.2m
Receivables 501.7m
Other Current Assets 100.4m
Non-Current Assets 1.1B
Long-Term Investments 39m
PP&E 739.5m
Intangibles 258.8m
Other Non-Current Assets 25.7m
Current Liabilities 390.5m
Accounts Payable 169.3m
Accrued Liabilities 79.1m
Short-Term Debt 59.4m
Other Current Liabilities 82.6m
Non-Current Liabilities 538.1m
Long-Term Debt 458.5m
Other Non-Current Liabilities 79.6m
Efficiency

Earnings Waterfall
SOL SpA

Revenue
1.5B EUR
Cost of Revenue
-404.3m EUR
Gross Profit
1.1B EUR
Operating Expenses
-855m EUR
Operating Income
227.9m EUR
Other Expenses
-82.2m EUR
Net Income
145.7m EUR

Free Cash Flow Analysis
SOL SpA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

SOL Profitability Score
Profitability Due Diligence

SOL SpA's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 3-Year Average ROE
Positive Free Cash Flow
58/100
Profitability
Score

SOL SpA's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

SOL Solvency Score
Solvency Due Diligence

SOL SpA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
50/100
Solvency
Score

SOL SpA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SOL Price Targets Summary
SOL SpA

Wall Street analysts forecast SOL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOL is 38.76 EUR with a low forecast of 38.38 EUR and a high forecast of 39.9 EUR.

Lowest
Price Target
38.38 EUR
14% Upside
Average
Price Target
38.76 EUR
15% Upside
Highest
Price Target
39.9 EUR
19% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

SOL Price
SOL SpA

1M 1M
+1%
6M 6M
+23%
1Y 1Y
+22%
3Y 3Y
+110%
5Y 5Y
+212%
10Y 10Y
+593%
Annual Price Range
33.6
52w Low
24.65
52w High
36.15
Price Metrics
Average Annual Return 16.56%
Standard Deviation of Annual Returns 31.31%
Max Drawdown -34%
Shares Statistics
Market Capitalization 3B EUR
Shares Outstanding 90 700 000
Percentage of Shares Shorted
N/A

SOL Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

SOL SpA Logo
SOL SpA

Country

Italy

Industry

Chemicals

Market Cap

3B EUR

Dividend Yield

0%

Description

SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. The company is headquartered in Monza, Monza E Brianza. The company is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.

Contact

MONZA E BRIANZA
Monza
Via Borgazzi, 27
+3903923961.0
http://www.sol.it/

IPO

1998-07-01

Employees

4 786

Officers

Chairman, Co-CEO & MD
Engineer Aldo Fumagalli Romario
Deputy Chairman, Co-CEO & MD
Mr. Marco Annoni
Director of Legal & Corporate Business and Director
Mr. Giulio Fumagalli Romario
Director of Information Systems & Director
Mr. Giovanni Annoni
CFO & Manager
Marco Filippi
Executive Director
Duccio Alberti

See Also

Discover More
What is the Intrinsic Value of one SOL stock?

The intrinsic value of one SOL stock under the Base Case scenario is 22.62 EUR.

Is SOL stock undervalued or overvalued?

Compared to the current market price of 33.6 EUR, SOL SpA is Overvalued by 33%.